NASDAQ: FRPTFreshpet Inc Stock
$71.79-0.36 (-0.5%)
Updated Jul 3, 2025
FRPT Price
$71.79
Fair Value Price
N/A
Market Cap
$3.50B
52 Week Low
$67.03
52 Week High
$164.07
P/E
211.15x
P/B
3.34x
P/S
4x
PEG
2.25x
Dividend Yield
N/A
Revenue
$1.01B
Earnings
$15.63M
Gross Margin
40.6%
Operating Margin
2.85%
Profit Margin
1.5%
Debt to Equity
0.49
Operating Cash Flow
$154M
Beta
1.23
Next Earnings
Aug 11, 2025
Ex-Dividend
N/A
Next Dividend
N/A
FRPT Overview
Freshpet, Inc. manufactures and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe. The company sells its products under the Freshpet brand; and Dognation and Dog Joy labels through various classes of retail, including grocery, mass, club, pet specialty, and natural, as well as online. Freshpet, Inc. was incorporated in 2004 and is headquartered in Secaucus, New Jersey.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FRPT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
C
FRPT
Ranked#50 of 52
Ranked#50 of 52
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $15.59 | A | |
| $13.72 | A | |
| $137.35 | A |
Be the first to know about important FRPT news, forecast changes, insider trades & much more!
FRPT News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FRPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FRPT ($71.79) is trading above its intrinsic value of $13.35, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FRPT is poor value based on its earnings relative to its share price (211.15x), compared to the US market average (30.96x)
P/E vs Market Valuation
FRPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FRPT due diligence checks available for Premium users.
Valuation
FRPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
211.15x
Industry
20.08x
Market
30.96x
FRPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FRPT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FRPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.34x
Industry
1.76x
FRPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
FRPT price to earnings growth (PEG)
For valuing profitable companies with growth potential
FRPT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
FRPT's financial health
Profit margin
Revenue
$263.2M
Net Income
-$12.7M
Profit Margin
-4.8%
FRPT's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
FRPT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$509.5M
Debt to equity
0.49
FRPT's short-term assets ($405.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FRPT's long-term liabilities ($426.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FRPT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
FRPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.8M
Investing
-$26.5M
Financing
-$3.2M
FRPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FRPT vs Food Stocks
Freshpet Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.